Mark Rodgers

Jan 15, 2025 | cell.com | Joshua Bromley |Sarah K. Nyquist |Pauline Maiello |Michael C. Chao |H. Jacob Borish |Mark Rodgers | +16 more

Main text(Immunity 57, 2380–2398.e1–e6; October 8, 2024)Following publication, we, the authors, identified three inadvertent errors. First, we realized that the data from the naive macaque control animals, specifically Mtb CFU and barcoding and PET-CT data, were previously published (see reference 9, Ganchua et al., in the references list). These macaques were originally part of the present study but were used as controls for another similar study that was submitted at the same time.

Jan 9, 2025 | nature.com | Yao Liu |Pauline Maiello |Andrew Simonson |Mark Rodgers |Dirk Schnappinger |Sabine Ehrt

AbstractImproved vaccination strategies for tuberculosis are needed. Intravenous (i.v.) delivery of live attenuated Mycobacterium bovis BCG provides protection against Mycobacterium tuberculosis (Mtb) in macaques but poses safety challenges. Here we genetically engineered two strains, BCG-TetON-DL and BCG-TetOFF-DL, to either induce or inhibit expression of two phage lysin operons, respectively, upon tetracycline exposure.